Tweet
Leaders in dermatology at Osurnia® Roadshow advise vets to bring first-line OE treatment back into practice to improve outcomes
· Free CPD available online with lecture recording at http://bit.ly/29kAiQv
Vets and vet nurses can gain free CPD and learn from leaders in dermatology about improving compliance and clinical outcomes in canine otitis externa* (OE) cases on the Osurnia website.
Elanco Animal Health hosted a series of free CPD events at vet schools across the UK where expert speakers addressed the common challenges of diagnosing and treating OE.
The final lecture in the Osurnia Roadshow, led by expert dermatology specialist Sue Paterson, is now available online, offering free CPD for all vets and vet nurses.
Osurnia, voted Best New Veterinary Product 2015 at the VMA Awards**, puts the control back into vets’ hands, with just two doses, one week apart. Speaking at the event at Rutland House Hospital in St Helens, Sue described how reclaiming the role of treatment administration for OE cases can help vets boost positive outcomes over and above clinical improvement:
“Clients often don’t use the topical ear products we give them. The beauty of Osurnia is that it’s something we can do in the surgery. It also helps to get them back into practice, allowing you to check the dog’s ear as well as bond more with that client - that’s very important when managing otitis cases.”
Although it’s one of the most common reasons for presentation to the vet, affecting around 1 in 5 dogs2, clinical resolution of OE can be tricky to achieve with owner compliance ranked by vets as one of the main reasons behind treatment failure.3
The interactive question and answer sessions with the expert speaker and an Elanco Veterinary Technical Consultant proved particularly popular, offering delegates the chance to discuss topics ranging from diagnostic tips to the practicalities of boosting compliance and clinical resolution.
Sue described how acute cases of OE should be tackled:
“For me, Osurnia is a great first-line product and I use it because of the benefits for owner compliance and its spectrum of activity for gram positive infections. If we manage acute disease much better, we will see fewer chronic and recurrent cases – if we manage them better, they’re less likely to progress to pseudomonas.”
Potts Redmond, who attended the final Roadshow in St Helens, said it was great to have the advice of a specialist in relation to managing such a common condition:
“Sue's assessment of Osurnia suggests it is likely to be a good first choice for acute OE cases, which echoes the results I've seen so far. Administering the product in the consultation takes the onus away from clients who can find it very stressful. Clients are more likely to return for the second treatment, rather than using a week of drops, perceiving the ear to be 'better' and not returning for the crucial recheck.
“This CPD definitely gave me more confidence to continue using Osurnia as a first-line treatment for acute OE, as well as valuable hints and tips that will help me in practice.”
If you missed out on the Osurnia Roadshow or just want to recap on diagnosis and management of canine OE, the webinar featuring Sue Paterson’s presentation and the interactive Q&A session can be found online at http://bit.ly/29kAiQv
To find out more about first-line treatment Osurnia and how Elanco can support dermatology in your practice, please contact your Elanco representative. References:
1. Osurnia Roadshow lectures (2016) -http://www.elancoanimalhealth.co.uk/...na/videos.aspx
2. Angus J C: Otic cytology in health and disease. Vet Clin. Small Animal; 2004, 34, 411-424
3. Industry survey of 341 UK practising vets, February 2016, commissioned by Elanco Animal Health
* Osurnia is for the treatment of acute otitis externa and acute exacerbation of recurrent otitis externa associated with Staphylococcus pseudintermedius andMalassezia pachydermatis in dogs.
**Online survey conducted on 290 small animal vets in March 2016, conducted by CM Research